Back to Search
Start Over
Percutaneous Thrombectomy with the JETi8 Peripheral Thrombectomy System for the Treatment of Deep Vein Thrombosis.
- Source :
-
Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2020 Mar; Vol. 31 (3), pp. 444-453.e2. Date of Electronic Publication: 2020 Jan 22. - Publication Year :
- 2020
-
Abstract
- Purpose: This study evaluated the safety and efficacy of the JETi8 peripheral thrombectomy system in treating acute deep vein thrombosis (DVT).<br />Materials and Methods: A retrospective study was conducted in 18 consecutive patients (mean age, 41 years old [range, 15-74 years old]; 5 men and 13 women). There were 21 instances of DVTs (9 iliofemoral, 10 axillosubclavian, and 2 portal), which were treated using the JETi8 thrombectomy device between November 2016 and July 2018. Thrombus was laced with recombinant tissue plasminogen activator (r-TPA) (9.3 mg, on average; range, 2-12 mg) in 17 procedures (81%) prior to thrombectomy. Technical success was defined as restoration of antegrade flow using the JETi8 with or without additional treatment of an underlying obstructive lesion. Procedural success was defined as technical success with or without the addition of overnight catheter-directed thrombolysis (CDT) RESULTS: Mean procedure time was 83 minutes (range, 30-160 minutes), and mean thrombus reduction with the JETi8 alone was 92% (range, 60%-100%). Stent placement was required in 6 procedures (29%). Technical success using the JETi8 system alone was 76% (16 of 21 procedures), whereas 5 procedures (24%) required subsequent overnight CDT in the intensive care unit. Procedural success rate was 100% (20 of 20 procedures). Mean aspirated volume was 531 mL (range, 250-1,230 mL). The only adverse event was a subsegmental pulmonary embolism. Seven patients (33%) were discharged the same day. Recurrent thrombosis was observed in 5 patients (24%), of whom 3 were successfully treated with the JETi8 system.<br />Conclusions: The JETi8 system may be a safe and effective option for thrombectomy of acute DVT.<br /> (Copyright © 2019 SIR. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adolescent
Adult
Aged
Angioplasty, Balloon instrumentation
Female
Fibrinolytic Agents administration & dosage
Humans
Male
Middle Aged
Quebec
Recombinant Proteins administration & dosage
Recurrence
Retreatment
Retrospective Studies
Risk Factors
Stents
Thrombectomy adverse effects
Thrombolytic Therapy
Time Factors
Tissue Plasminogen Activator administration & dosage
Treatment Outcome
Vascular Patency
Venous Thrombosis diagnostic imaging
Venous Thrombosis etiology
Venous Thrombosis physiopathology
Young Adult
Thrombectomy instrumentation
Venous Thrombosis therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1535-7732
- Volume :
- 31
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of vascular and interventional radiology : JVIR
- Publication Type :
- Academic Journal
- Accession number :
- 31982312
- Full Text :
- https://doi.org/10.1016/j.jvir.2019.10.022